Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Moore

Showing results (1011-1020 of 2,067) with videos related to

Pageof 207
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatinA Sahu, A M Soulika, D Morikis, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 29, 2019
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEWMazen Al Mushref, Paul A Guido, Frances A Collichio, et al.
Journal of Neuroscience Research|February 15, 1993
Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's diseaseW K Liu, W T Moore, R T Williams, et al.
Thrombosis Research|September 2, 2025
Characteristics and outcomes of venous thromboembolism-related litigation in orthopaedic surgeryHaad A Arif, Andrew Miner, Simon T Moore, et al.
European Journal of Clinical Nutrition|February 23, 2017
Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysisD Q Holt, P Varma, B J G Strauss, et al.
Age and Ageing|January 1, 1988
Epidemiology of intermittent claudication: evaluation of risk factorsW E Hale, R G Marks, F E May, et al.
Investigative Ophthalmology & Visual Science|February 22, 2014
Visual consequences of molecular changes in the guanylate cyclase-activating proteinAndrew Stockman, G Bruce Henning, Anthony T Moore, et al.
Bulletin of Environmental Contamination and Toxicology|August 14, 1998
Responses of non-target aquatic organisms to aqueous propanil exposureM T Moore, J R Pierce, C D Milam, et al.
The Journal of Chemical Physics|December 21, 2006
Photodissociation dynamics of ClN3 at 193 nmScott J Goncher, Niels E Sveum, David T Moore, et al.
Journal of Clinical Epidemiology|January 1, 1991
A longitudinal evaluation of drug use in an ambulatory elderly populationR B Stewart, M T Moore, F E May, et al.
Pageof 207

Showing results (1011-1020 of 2,067) with videos related to

Sort By:
Pageof 207
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatinA Sahu, A M Soulika, D Morikis, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 29, 2019
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEWMazen Al Mushref, Paul A Guido, Frances A Collichio, et al.
Journal of Neuroscience Research|February 15, 1993
Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's diseaseW K Liu, W T Moore, R T Williams, et al.
Thrombosis Research|September 2, 2025
Characteristics and outcomes of venous thromboembolism-related litigation in orthopaedic surgeryHaad A Arif, Andrew Miner, Simon T Moore, et al.
European Journal of Clinical Nutrition|February 23, 2017
Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysisD Q Holt, P Varma, B J G Strauss, et al.
Age and Ageing|January 1, 1988
Epidemiology of intermittent claudication: evaluation of risk factorsW E Hale, R G Marks, F E May, et al.
Investigative Ophthalmology & Visual Science|February 22, 2014
Visual consequences of molecular changes in the guanylate cyclase-activating proteinAndrew Stockman, G Bruce Henning, Anthony T Moore, et al.
Bulletin of Environmental Contamination and Toxicology|August 14, 1998
Responses of non-target aquatic organisms to aqueous propanil exposureM T Moore, J R Pierce, C D Milam, et al.
The Journal of Chemical Physics|December 21, 2006
Photodissociation dynamics of ClN3 at 193 nmScott J Goncher, Niels E Sveum, David T Moore, et al.
Journal of Clinical Epidemiology|January 1, 1991
A longitudinal evaluation of drug use in an ambulatory elderly populationR B Stewart, M T Moore, F E May, et al.
Pageof 207